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Objective: In diabetes mellitus several cardiac electrophysiological parameters are known to be affected. In rodent experimental diabetes
models changes in these parameters were reported, but no such data are available in other mammalian species including the dog. The present
study was designed to analyse the effects of experimental type 1 diabetes on ventricular repolarization and its underlying transmembrane
ionic currents and channel proteins in canine hearts.
Methods and results: Diabetes was induced by a single injection of alloxan, a subgroup of dogs received insulin substitution. After the
development of diabetes (8 weeks) electrophysiological studies were performed using conventional microelectrodes, whole cell voltage clamp,
and ECG. Expression of ion channel proteins was evaluated byWestern blotting. TheQTc interval and the ventricular action potential duration in
diabetic dogs were moderately prolonged. This was accompanied by significant reduction in the density of the transient outward K+ current (Ito)
and the slow delayed rectifier K+ current (IKs), to 54.6% and 69.3% of control, respectively. No differences were observed in the density of the
inward rectifier K+ current (IK1), rapid delayed rectifier K
+ current (IKr), and L-type Ca
2+ current (ICa). Western blot analysis revealed a reduced
expression of Kv4.3 and MinK (to 25±21% and 48±15% of control, respectively) in diabetic dogs, while other channel proteins were
unchanged (HERG, MiRP1, α1c) or increased (Kv1.4, KChIP2, KvLQT1). Insulin substitution fully prevented the diabetes-induced changes in
IKs, KvLQT1 and MinK, however, the changes in Ito, Kv4.3, and Kv1.4 were only partially diminished by insulin.
Conclusion: It is concluded that type 1 diabetes mellitus, although only moderately, lengthens ventricular repolarization, attenuates the
repolarization reserve by decreasing Ito and IKs currents, and thereby may markedly enhance the risk of sudden cardiac death.
© 2006 European Society of Cardiology. Published by Elsevier B.V.Keywords: Diabetes mellitus; QT interval; Potassium channels; Channel proteins; Repolarization reserve1. Introduction
It has been reported that both type 1 and type 2 diabetes
mellitus are associated with increased risk of sudden cardiac⁎ Corresponding author. Department of Pharmacology and Pharmacother-
apy, University of Szeged, H-6720 Szeged, Dóm tér 12, P.O. Box 427,
Hungary. Tel.: +36 62 545 682; fax: +36 62 545 680.
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0008-6363/$ - see front matter © 2006 European Society of Cardiology. Publish
doi:10.1016/j.cardiores.2006.11.010death [1,2], which can not easily be attributed to general
pathophysiological changes such as atherosclerosis, hyperli-
pidaemia, hypertension or heart failure. In type 1 diabetes
mellitus prolongation of the QTc interval and increased QTc
dispersion were observed [3,4]. It was speculated that this
increased QTc interval, similarly to non-diabetic subjects
with QTc prolongation, can be related to the excess risk of
mortality [5–7]. Studies in identical twins also showed that
QTc was longer in type 1 diabetic than in non-diabeticed by Elsevier B.V.
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due to diabetes rather than genetic factors [8]. The cellular
mechanisms of lengthening of repolarization and increased
susceptibility to ventricular arrhythmia and sudden cardiac
death in type 1 diabetes mellitus are poorly understood. Earlier
studies designed to elucidate the cellular mechanisms of
diabetes-induced repolarization abnormalities were performed
in rats [9–12]. These studies suggested that the decreased
amplitude of the transient outward K+ current (Ito) and the
reduced expression of Kv4.3 and Kv4.2 channel proteins were
responsible for the elongation of repolarization in diabetic rats
[13,14]. However, ventricular repolarization in rats involves
distinctly different mechanisms than in other mammals
including dogs and humans, since it lacks a prominent plateau
phase and has a short duration. Therefore, these results
obtained in rats have limited value in understanding the
repolarization abnormalities observed in insulin-dependent
patients. Realizing this limitation, in this study the electro-
physiological changes and alterations in expression of the
underlying ion channel proteins induced by experimental type
1 diabetes were investigated in the dog, i.e. in a species having
cardiac repolarization and pattern of cardiac ion currents more
resembling those of the human heart.
2. Methods
2.1. Experimental protocol
Adult mongrel dogs of either sex, weighing 21–32 kg
(n=60), were used in these experiments. Altogether in 51
dogs infusion of a single intravenous dose of alloxan was
applied in order to induce diabetes mellitus (560 μmol/kg
alloxan monohydrate, Sigma, St Louis, MO, USA). 12 dogs
died within 72 h after the alloxan infusion, and diabetes was
not induced in 11 dogs. In the diabetes period 5 dogs died in
the untreated and 1 dog in the insulin-treated groups.
Another 7 dogs (1 in control group, 4 in diabetes group and 2
in insulin-treated diabetes group) were omitted from the
experiments because of technical reason. This attrition rate is
expected and were reported previously [15].
The diabetes-inducing agent alloxan is reported to cause
destruction of pancreatic islet beta-cells. The destruction is
associated with pancreatic beta-cell DNA injury related to free
radicals. The pancreatic islets are relatively susceptible to
active oxygen, and are more easily damaged than other tissues.
This is because the activities of antioxidant enzymes such as
superoxide dismutase are low in pancreatic islet beta-cells [16].
Development of diabetes was confirmed by intravenous
glucose tolerance test 1 week later. 8 from the 16 alloxan-
treated dogs received insulin substitution (0.5–1.0 IU/kg
day−1 s.c., Humulin N, Eli Lilly, USA) to maintain normo-
glycaemia. Insulin treatment was initiated 1 week after the
injection of alloxan and was maintained throughout the entire
experiment. The untreated animals were used as controls.
Body weight and plasma glucose levels were determined
in each animal at the beginning as well as at the end of theexperiment (8 weeks after the alloxan injection). The plasma
potassium and urea nitrogen values were also determined.
These data, verifying the diabetic state of the animals, are
presented in Table 1. The thyroid hormone levels (free T3
and T4) were measured by electrochemiluminescence
immunoassay (ECLIA, Roche Diagnostics). At the end of
the experiment, the animals were sacrificed under anaesthe-
sia induced by intravenous infusion of 0.25 mg/kg
midazolam plus 10 mg/kg ketamine. The hearts were rapidly
removed and tissues for cellular electrophysiological mea-
surements and for Western blot studies were excised.
All experiments were carried out in compliance with the
Guide for the Care and Use of Laboratory Animals (USA
NIH publication NO 85–23, revised 1985). The protocols
were approved by the Review Board of the Committee on
Animal Research of the University of Szeged (54/1999 Oej).
2.2. Electrocardiography
Conventional ECG recordings were taken from each
animal under anaesthesia at the beginning and the end of the
experiment. All leads were sampled by an ECG signal
processing system (Haemosys, Experimetria Ltd, Budapest,
Hungary) under the control of a personal computer. Fol-
lowing analogue-to-digital conversion, the data were digi-
tally stored and analyzed off-line. ECG parameters (RR, PQ,
QRS, QT and QTc intervals) were determined manually
using cursors. QT intervals were measured on lead II from the
QRS onset to the end of the T wave. QTc intervals were
derived according to the Fridericia formula [QTc=QT/RR
1/3]
[17]. ECG parameters were averaged from 3 consecutive
complexes analyzed always by a single observer.
2.3. Recording of action potentials from ventricular
myocardium
After opening the chest the heart was quickly removed.
Thin papillary muscles were excised from the right ventricle
and immersed in oxygenated modified Locke's solution
containing (in mM): NaCl 120, KCl 4, CaCl2 1.0, MgCl2 1,
NaHCO3 22 and glucose 11. The pH of this solution was set
to 7.4±0.05 when saturated with the mixture of 95% O2 and
5% CO2 at 37 °C. Transmembrane action potentials were
recorded using the conventional microelectrode technique.
Recordings were taken from 3 distinct impalements in the
case of each animal. The preparations were stimulated at a
frequency of 2 Hz using rectangular constant current pulses
of 2 ms duration delivered through a bipolar platinum
electrode. At least 1 h was allowed for each preparation to
equilibrate before beginning of the measurements. Micro-
electrodes, filled with 3 M KCl and having tip resistances of
5–20 MΩ, were connected to the input of a high impedance
electrometer (HSE, type 309 microelectrode amplifier). Data
acquisition was performed with an ADA 3300 analogue-to-
digital board (Real Time Devices Inc., State College, PA,
USA.) using a maximum sampling rate of 40 kHz.
Table 1
Changes in body weight and plasma constituents during the experimental period in dogs
Dog Control (n=8) Diabetic (n=8) Insulin-treated (n=8)
Initial Final Initial Final Initial Final
Body weight (kg) 25.1±2.0 25.9±2.2 27±1.2 22.2±2.1⁎† 24.6±1.3 23.6±0.7
Glucose (mM) 4.7±0.2 4.8±0.1 4.8±0.3 19.4±2.8⁎† 4.3±0.3 6.4±0.7⁎†
Potassium (mM) 4.5±0.1 4.6±0.1 4.5±0.1 4.9±0.1⁎† 4.4±0.2 4.6±0.2
Urea nitrogen (mM) 3.9±0.3 3.8±0.3 4.0±0.8 6.8±0.9† 4.7±0.4 6.9±0.5⁎†
Free T3 level (pM) 2.75±0.18 3.55±0.45 4.23±0.26
Free T4 level (pM) 9.62±0.66 9.98±1.03 11.09±1.37
The experimental period lasted for 8 weeks. Data represent means±SEM, asterisks denote significant changes between the initial and final states determined
using Student's t-test for paired data, † indicates significant differences comparing to the control group calculated with Student's t-tests for unpaired data
( pb0.05).
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Canine left midmyocardial ventricular myocytes were
enzymatically dissociated using the segment perfusion tech-
nique, as described earlier in detail [18]. One drop of cell
suspension was placed within a transparent recording cham-
ber mounted on the stage of an inverted microscope, and
individual myocytes were allowed to settle and adhere to the
bottom of the chamber for at least 5 min before superfusion
was initiated. HEPES buffered Tyrode's solution was used as
the normal superfusate. This solution contained (in mM):
NaCl 144, NaH2PO4 0.33, KCl 4.0, CaCl2 1.8, MgCl2 0.53,
Glucose 5.5, and HEPES 5.0 at pH of 7.4. All experiments
were performed at 37 °C.
Patch-clamp micropipettes were fabricated from borosil-
icate glass capillaries using a P-97 Flaming/Brown micro-
pipette puller (Sutter Co, Novato, CA, USA). These
electrodes had resistances between 1.5 and 2.5 MΩ after
filling with pipette solution containing (in mM): K-aspartate
100, KCl 25, ATP 3, MgCl2 1, EGTA 10 and HEPES 5, or
KCl 110, KOH 40, EGTA 10, HEPES 10, TEACl 20,
MgATP 5, GTP 0.25, when measuring K+ and Ca2+ currents,
respectively. The pH of the pipette solution was adjusted to
7.2 by KOH.
Membrane currents were recorded with Axopatch-1D and
200B patch-clamp amplifiers (Axon Instruments, Union
City, CA, USA) using the whole cell configuration of the
patch-clamp technique. The series resistance was typically
4–8 MΩ before compensation (50–80%, depending on the
voltage protocols). Membrane currents were digitized using
a 333 kHz A/D converter (Digidata 1200, Axon Instruments)
under software control (pClamp 8, Axon Instruments, Union
City, CA, USA) after low-pass filtering at 1 kHz. Membrane
currents were normalized to cell capacitance, determined by
applying 10 mV hyperpolarizing pulses at − 10 mV. Voltage
protocols used for measuring specific ion currents are
described in the appropriate section of results.
2.3.2. Western blotting
Ion channel proteins from control, diabetic, and insulin-
treated canine hearts (n=8 in each group) were obtained
using a method modified after Han et al. [19]. Briefly, tissues
were pulverized in liquid N2 and suspended in ice-cold TEbuffer (20 mM Tris, 1 mM EDTA, and 1:100 dilution of
Protease inhibitor cocktail containing at final concentrations:
1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 0.8 μM
aprotinin, 20 μM leupeptin, 40 μM bestatin, 15 μM pepstatin
A, and 14 μM E-64) (all purchased from Sigma–Aldrich,
St. Louis, MO, USA). The suspension was disrupted by
sonication on ice (3×20 s) and was centrifuged at 100,000 g
for 90 min at 4 °C. The resulted pellet was then resuspended
in ice-cold TE buffer containing 2% Triton X-100 (Sigma)
and was again centrifuged at 100,000 g for 45 min at 4 °C.
The protein content of the resulted supernatant (membrane
fraction) was measured by a modified BCA protein assay
(Pierce, Rockford, IL, USA). Samples were then mixed with
SDS-PAGE sample buffer, subjected to SDS-PAGE accord-
ing to Papp et al. [20] (8% gels were loaded with vigorously
equal amounts of 40 μg protein per lane) and transferred to
nitrocellulose membranes (BioRad, Wien, Austria). Mem-
branes were blocked (1 h, room temperature) with 5% nonfat
dry milk in phosphate-buffered saline (PBS) and incubated
overnight with the following primary antibodies (1:50–1:100
dilution in milk-PBS containing 0.1% Tween 20, PBST);
polyclonal rabbit anti-Kv 1.4, anti-α1C, anti-MinK, anti-
HERG, anti-MIRP1 (all form Alomone Labs, Jerusalem,
Israel), polyclonal goat anti-KChIP2 and anti-KvLQT1 (from
Santa Cruz Biotech, Santa Cruz, CA, USA). After 3 washes in
PBST, membranes, in the cases of the rabbit primary antibody
staining, were incubated with an anti-rabbit ABC kit (Vector
Laboratories, Burlingame, CA, USA), as suggested by the
manufacturer. In the case of the goat anti-KChIP2 labelling,
membranes were first incubated with a rabbit anti-goat sec-
ondary antibody (1:1000 dilution in milk-PBST, BioRad) and
then with the above anti-rabbit ABC kit. Immunoreactive
bands were visualized by an ECL Western blotting detec-
tion kit (Pierce) on light sensitive film (AGFA, Brussels,
Belgium). For obtaining negative controls, samples were also
probed with primary antibodies preincubated with antigenic
(control) peptides; in all cases, the specific staining was
suspended by the presence of the control peptide (data not
shown). Band density was quantified using a GelDoc instru-
ment (BioRad) on films exposed and processed equally, as
described before [20]. Densitometric values of the individual
lanes were normalized to those obtained for the control
Fig. 1. Representative action potential recordings measured in ventricular
papillary muscle originating from control (left panel), diabetic (middle
panel) and insulin-treated diabetic (right panel) dogs. Insets show a
magnification of the early repolarization phase of the action potential.
Stimulation frequency was 1 Hz. Dotted lines indicate zero potential level.
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pressed as percentage of control (100%).
2.4. Statistical analysis
Results were compared using Student's t-tests for paired
or unpaired data as appropriate. Differences were considered
significant when pb0.05. Data are expressed as mean±
SEM.
3. Results
3.1. Effect of diabetes on ventricular repolarization
Diabetes induced a moderate, but statistically significant,
lengthening of ventricular repolarization, which was pre-
vented by insulin substitution. Results obtained from ECG
recordings (QTc) and from isolated papillary muscle prepa-
rations (APD) are summarized in Table 2. Lengthening of
repolarization was the single diabetic alteration observed,
since neither the heart rate (RR interval), nor the velocity of
atrio-ventricular (PQ interval) and intraventricular (QRS
duration) conduction was significantly modified by alloxan
or insulin. The angles of the QRS and T-wave vectors were
also unchanged in diabetic and insulin-treated diabetic dogs
(Table 2). Action potential configuration was also charac-
teristically altered in diabetic dogs: phase-1 repolarization
became attenuated (Fig. 1). Similar to changes in repolar-
ization, this effect was prevented by insulin treatment.
3.2. Diabetes-induced changes in ionic currents
Steady-state current–voltage relationship of the mem-
brane was determined by applying 400 ms long voltage
pulses to test potentials ranging from −120 mV to +60 mV,
arising from the holding potential of −90 mV. Membrane
currents measured at the end of these pulses were plotted
against their respective test potentials. The negative branch
of the I–V curve is associated with IK1. As shown in Fig. 2A,
no significant differences were observed in the steady-state
current–voltage relationship, and consequently, in the den-
sity of IK1, in ventricular myocytes obtained from control,
diabetic, and insulin substituted dogs.Table 2
Changes in ECG parameters and action potential duration during the 8 weeks exp
Dog RR (ms) PQ (ms) QRS (ms) QT (ms) QTc (ms)
Initial Control 335±20.0 106±3.9 53±2.4 196±3.8 283±2.9
DM 342±16.5 105±3.6 55±1.9 198±5.7 284±4.5
DM+insulin 319±16.5 104±5.0 57±2.7 193±5.7 283±4.6
Final Control 346±24.4 106±1.9 54±2.3 199±6.3 284±4.2
DM 330±19.2 102±3.6 55±2.2 208±6.4 302±8.8⁎
DM+insulin 304±17.8 105±3.7 54±2.5 187±3.2 280±5.4
Data represent means±SEM. Asterisks denote significant changes between the ini
paired data ( pb0.05). † indicates significant differences comparing to the respective
( pb0.05). # indicate significant differences comparing to the respective value in
( pb0.05). ECG and action potential measurements (19–25 impalements) were mIKr was activated by 1 s long depolarizing test pulses to
membrane potentials ranging from −20 mV to +50 mV at
frequency of 0.05 Hz. The amplitude of the tail current,
measured upon returning to the holding potential of −40 mV,
was plotted as a function of the activation voltage and was
used to define the magnitude of IKr. These experiments were
performed in the presence of 1 μM nisoldipine and 30 μM
chromanol 293B in order to suppress ICa and IKs, respec-
tively. Results displayed in Fig. 2B indicate that neither the
amplitude of IKr, nor the voltage-dependence of its activation
was altered in the alloxan-induced diabetes or by the applied
insulin substitution.
ICa was recorded in the presence 3 mM 4-aminopyridine
in order to block Ito. The current was evoked by 400 ms long
depolarizing test pulses to voltages between −40 to +55 mV,
arising from the holding potential of −40 mV. Peak values
of ICa were plotted against the respective test potentials
(Fig. 2C). The density of ICa was not significantly different in
the control, diabetic and insulin-treated groups, having also
similar voltage-dependence of activation.
Ito was evoked in the presence of 1 μM nisoldipine by
applying 400 ms long test depolarizations to voltages ranging
from −20 to +50 mV. These depolarizations were arising
from the holding potential of −90 mV, and were separated by
3 s long interpulse intervals. The amplitude of Ito was definederimental period
QRS-vector (degree) T-wave vector (degree) APD50 (ms) APD90 (ms)
81.7±3.0 85.6±0.5
81.4±3.0 83.0±1.4
82.8±1.3 84.4±1.2
84.3±1.7 86.7±0.8 191.2±4.0 225.0±4.0
85.1±0.9 83.0±1.6 205.2±4.7† 242.8±5.6†
84.0±1.2 85.7±1.1 180.7±3.1†# 213.1±3.6†#
tial (0 week) and final states (8 week) determined using Student's t-test for
value in the control group calculated with Student's t-tests for unpaired data
the diabetes group (DM) calculated with Student's t-tests for unpaired data
ade from 8 dogs in each group.
Fig. 2. Effect of diabetes and insulin substitution on the current–voltage (I–V) relationships obtained for IK1 (A), IKr (B) and ICa (C) in canine ventricular
myocytes. A segment of the I–V curve between −80 and 0 mV is enlarged in the inset of panel A. Symbols and bars represent mean values±SEM; n indicates the
number of cells.
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outward current and the steady-state current (recorded at the
end of the test pulse). Amplitude of Ito was significantly
smaller in diabetic myocytes than in cells isolated from the
control animals (9.54±1.11 pA/pF versus 17.39±1.92 pA/pF
at +50 mV, pb0.05, n=35 and 32, respectively), however,
the voltage-dependence of activation remained unaltered
(Fig. 3). Similarly, the inactivation kinetics of Ito was not
modified by diabetes (the decay time constant was 5.2±
0.11 ms in control, n=29; and 5.5±0.21 ms in diabetes,Fig. 3. Diabetes-induced changes in the amplitude of Ito in dog ventricular myocyte
right panels, respectively. Symbols and bars represent mean values±SEM, dashed
significant differences ( pb0.05) from control.n=27). The diabetes-induced suppression of Ito could be only
partially prevented by insulin substitution.
IKs was activated by depolarizing test pulses of 5 s
duration clamped to membrane potentials ranging between
−20 mV and +50 mV and applied at frequency of 0.1 Hz.
The amplitude of the tail current measured upon repolariza-
tion to the holding potential of −40 mV was plotted against
the activation voltage and was used to define the magnitude
of IKs. In these experiments the external solution was
supplemented with 1 μM nisoldipine and 1 μM E-4031 ins. Ito families and current–voltage relationships are presented in the left and
lines indicate zero current level, and n=number of cells. Asterisks denote
Fig. 4. Suppressive effect of diabetes on the amplitude of IKs. Note the full prevention of diabetic alterations in myocytes obtained from insulin-treated hearts.
Symbols and bars represent mean values±SEM; n=cell number. Asterisks denote significant differences ( pb0.05) from control.
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Fig. 4, the amplitude of IKs was significantly less in diabetic
than in non-diabetic dogs (0.97±0.1 pA/pF versus 1.40±
0.13 pA/pF at +50 mV, pb0.05, n=32 and 31, Fig. 4)
Insulin substitution fully prevented the development of the
diabetes-induced reduction in IKs, i.e. identical IKs values
were recorded in the insulin-treated and control canine
myocytes within the entire voltage range.
3.3. Effect of diabetes on expression of ion channel proteins
Electrophysiological studies revealed significant reduc-
tion in the density of Ito and IKs in diabetic myocytes.Fig. 5. Expression of ion channel proteins (α-subunits and regulatory proteins)
representative Western blots are presented in the left panel (A). Samples were obtain
In the right side diagram (B) relative optical density (OD) values, generated by norm
control ones, are given in the ordinate. Dotted line indicates 100%. Columns and bar
each antigen. Asterisks denote significant differences ( pb0.05) from control.Therefore, expression of the underlying channel forming
proteins (α-subunits), together with some of their important
regulatory subunits, was compared in left ventricular myo-
cardial samples excised from control, diabetic, and insulin-
treated animals (n=8 in each group). Since our experimental
technique allowed only comparison of paired samples —
instead of determination of absolute density of channel
proteins— the optical densities obtained in the diabetic and
insulin-treated hearts were normalized to those measured in
the non-diabetic controls and expressed as percentage. As is
shown in Fig. 5, expression of α1C (pore-forming subunit of
the L-type Ca2+ channel), HERG and MiRP1 (pore-forming
and regulatory subunits of the IKr channel, respectively) werein dog ventricular myocardium determined by Western blotting. Series of
ed from non-diabetic control (C), diabetic (D), and insulin-treated (I) hearts.
alizing the results obtained from diabetic and insulin-treated preparations to
s represent mean±SEM values obtained from 8 independent experiments for
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of KvLQT1 and MinK (pore-forming and regulatory sub-
units of the IKs channel) was inversely affected by diabetes:
the density of MinK was reduced to 48±15%, while that of
KvLQT1 was elevated to 168±12% of the control. Similar
asymmetry was observed in distribution of channel proteins
responsible for mediation of Ito: the expression of Kv4.3 (the
major pore-forming subunit in dog) was decreased to 25±
21% of the control, while the density of Kv1.4 (less dom-
inant pore-forming subunit) and KChIP2 (regulatory sub-
unit) was significantly elevated in diabetic myocardium (to
235±34% and 163±29 5%, respectively). In accordance
with results of the voltage clamp studies, the diabetes-
induced changes in MinK and KvLQT1 expression were
fully prevented by insulin substitution. In the case of Kv4.3
and Kv1.4 only partial prevention could be achieved, while
the concomitant change in KChIP2 density was not affected
by insulin at all.
4. Discussion
To the best of our knowledge this is the first report
describing diabetes-induced changes in cardiac ion currents
and the underlying ion channel proteins in the dog, i.e. in a
species having ventricular repolarization very similar to that
of the human [18]. The major finding of this study is that
experimentally induced diabetes mellitus was associated
with only moderate lengthening of action potential duration
and QTc interval in canine heart, while causing marked
reduction of K+ currents (Ito and IKs) involved in ventricular
repolarization. Although the role of these currents in normal
repolarization (i.e. in healthy individuals) was questioned,
their importance under certain pathophysiological conditions
seems to be strongly increased [18,21–27]. Cardiac repolari-
zation is determined by several ion channels, including
numerous outward transmembrane K+ currents. Under nor-
mal conditions block of one type of K+ current does not
necessarily cause excessive lengthening of action potential
duration, since other types of K+ current may provide
sufficient repolarization. This concept was termed by Roden
as “repolarization reserve” [28–30]. These K+ currents may
compensate for each other to secure the repolarization
process [28–32]. If repolarization is excessively lengthened
due to the blockade of IKr, hypokalaemia, genetic abnor-
mality, or bradycardia, the subsequent increase in action
potential duration would facilitate the activation of IKs and
provide a negative feedback mechanism to limit further
lengthening [18,31–34]. Deficiency of such a mechanism in
case of inheritance (e.g. long QT syndromes) or acquired
disease (e.g. ion channel remodeling caused by heart failure,
acute myocardial infarction, or diabetes mellitus), may lead
to excessive prolongation of repolarization and increased
propensity for development of early afterdepolarizations
in response to a relatively weak inhibition of a K+ current
[35–39]. Therefore, it is likely that the decreased IKs in
diabetes mellitus would attenuate the repolarization reserve,and as such, it would increase the proarrhythmic risk
especially when Ito, another repolarizing potassium current,
is also diminished. Consequently, diabetic patients may carry
an increased proarrhythmic risk due to their compromised
repolarization reserve capacity even if their QTc interval is
close to normal. This must be born in mind when designing
pharmacotherapy for diabetic patients.
Several studies in the rat showed that experimentally
induced type 1 diabetes mellitus lengthened cardiac action
potential duration and decreased the amplitude of Ito [9–12].
This is consistent with our finding in the dog where both Ito
and Kv4.3 protein (the dominant pore-forming subunit in
canine, human and even in rabbit ventricle [40]) were found
to be downregulated. In previous experiments it was also
found that the density of Kv4.3 protein was decreased, while
the density of Kv1.4 protein was increased in type 1 diabetes
mellitus [13,14]. These results are congruent with our data
obtained in canine heart. The way by which the rapidly
inactivating Ito may contribute to repolarization is contro-
versial. It has to be emphasized, however, that following
inactivation of the fast component of Ito a second, slower
component of inactivation is also evident having a time
constant of 25–35 ms and amplitude of 200–300 pA. This
component of Ito is operating probably during the early phase
of plateau, and its possible reduction due to diabetes may
result in lengthening of repolarization.
The decreased density of IKs and expression of the
underlying regulatory β-subunit channel protein, MinK in
the diabetic heart is a new and important finding. It is
surprising, however, that this reduction of IKs was associated
with an increased expression of the pore-forming α-subunit,
KvLQT1. On the other hand there may be more direct
interactions between the KvLQT1 and HERG α-subunits of
IKs and IKr. KvLQT1 modulates the distribution and bio-
physical properties of HERG. It means that HERG current
density was approximately doubled by co-expression with
KvLQT1 [41]. It can be speculated, therefore, that down-
regulation of MinK is the primary consequence of diabetes
mellitus, and the concomitant upregulation of KvLQT1 can be
a secondary compensatory process, which may partially
oppose the consequences of the diabetes-induced down-
regulation of MinK. The opposite mechanism might operate
in the case of Ito, resulting in reduction of the Kv4.3 ex-
pression associated with the upregulation of Kv1.4 and
KChIP2. Patel et al. [42] proposed a Kv4.3 gating model
wherein KChIP2 isoforms accelerate recovery from inactiva-
tion, slow closed-state inactivation, and promote open-state
inactivation. Therefore, the upregulated KChIP2may slow the
inactivation at depolarized potentials increasing the current,
the repolarizing force in the plateau phase, and may promote
reopening of the Ito current upon membrane repolarization,
which may contribute to the late repolarization [42].
Deschenes and Tomaselli [43] reported that when MinK
was co-expressed with Kv4.3, the current density increased
about five-fold compared to Kv4.3 expressed alone, and the
inactivation and the recovery from inactivation kinetics of
519C. Lengyel et al. / Cardiovascular Research 73 (2007) 512–520Kv4.3 were slowed by MinK [43]. Therefore, the alteration
of MinK by diabetes might at least partly explain the
attenuation of Ito density in dog. It is also worthy of note that
insulin substitution was able to fully prevent the diabetes-
induced reduction of IKs (and the concomitant changes in the
expression of the underlying channel proteins), but had only
a limited protective effect in the case of Ito. The reason for
this discrepancy remains unclear, however, it can be
concluded that patients with type 1 diabetes — even when
they are properly treated with insulin — may carry an
increased proarrhythmic risk.
The mechanism by which diabetes mellitus can influence
expression of cardiac ion channels is not fully understood.
Elevation of the plasma free fatty acids in diabetes increases
the rate of β-oxidation and the subsequent formation of
amphiphillic metabolites, such as palmitoylcarnitine and
palmitoyl-CoA, which was shown to directly suppress Ito in
the rat heart [44], but the effects of these metabolites on ion
channel expression is unknown. Activation of the renin–
angiotensin system was also demonstrated in insulin-
dependent diabetic rats, and the increased level of angioten-
sin II attenuated Ito [45]. It was found that inhibition of the
formation or action of angiotensin II reversed the attenuated
Ito in both type 1 and type 2 diabetes. This observation can be
explained by the fact that angiotensin II has numerous and
diverse cellular effects mediated by protein kinase A, protein
kinase C, and tyrosine kinases, which may be linked to the
inhibition of certain transmembrane ionic channels [46].
Further studies are required to elucidate these details.
4.1. Limitations of the study
Several studies indicate that in terms of the densities and
kinetics of cardiac ion channels involved in ventricular
repolarization canine ventricular cells can best approximate
human ventricular myocytes. We propose, therefore, that
present observations using diabetic canine myocardium may
yield important conclusions. Previous results obtained
mostly from rat models are difficult to extrapolate to the
diabetic changes of human cardiac tissues at the level of ion
channels. However, the present results can be implicated to
diabetic patients with caution. First of all, the diabetic model
used in this study can relate only to type 1 diabetes, which
represents only the minority of the diabetic population.
Furthermore, human diabetes has a long lasting time course
extending for several decades after its diagnosis and insulin-
replacement therapy is applied in these patients. Therefore, it
is still uncertain how the changes in ionic currents and protein
densities observed in our experiments would actually
influence the repolarization reserve and proarrhythmic risk
in diabetic patients in general. The possible attenuation of the
repolarization reserve should be studied in patients and — if
confirmed — should be taken into account as an enhanced
proarrhythmic risk factor before pharmacotherapy is initiated.
Besides the importance of the decreased repolarization
reserve in diabetes, regional differences in APD and theunderlying ionic currents existing throughout the left ventric-
ular wall [47–49] may be differentially affected by diabetes as
it was reported in rat [50,51]. Also the electrophysiological
properties of the right and left ventricles are somewhat
different [52]. Therefore, in future studies it would be
important to address whether and to what extent the transmural
and interventricular gradients of the various ionic currents are
altered by diabetes and how they influence repolarization.
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